ArticleThe Lancet. Neurology2022
Riluzole and spinocerebellar ataxia type 2: the ATRIL trial.
Luis Velázquez-Pérez et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleThe Lancet. Neurology2022
Luis Velázquez-Pérez et al.PubMed ↗Publisher ↗
No numbers read from the abstract.